This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

Hanmi Cap, For Your Successful mRNA Research

Posted by on 21 June 2023
Share this article

In an interview at the TIDES USA conference in San Diego, Calif., Sung Jun Park, Project Manager, Global Business, at Hanmi Fine Chemical, discusses the company’s role as a leading CDMO company in South Korea and its expertise in manufacturing active pharmaceutical ingredients. Park highlights Hanmi’s recent expansion into mRNA raw materials and the company’s primary product, Hanmi Cap, a novel cap analog structure used in the in vitro transcription of mRNA. Additionally, Park shares recent developments in cap candidates for self-amplifying RNAs.

Share this article